FDA Releases Draft Guidance on Collecting Race and Ethnicity Data in Clinical Trials for FDA-Regulated Medical Products

Summary

The FDA is releasing a draft guidance to provide industry with standardized approach for collecting and reporting race and ethnicity data in submissions related to FDA-regulated medical products, aiming to ensure consistent data collection and reporting.